NDC 14783-049

LBel Paris Regression Jour

Avobenzone, Ensulizole, Octinoxate, And Oxybenzone

LBel Paris Regression Jour is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd. The primary component is Avobenzone; Ensulizole; Octinoxate; Oxybenzone.

Product ID14783-049_35041b4f-d141-4cf0-91c9-829ff347fe90
NDC14783-049
Product TypeHuman Otc Drug
Proprietary NameLBel Paris Regression Jour
Generic NameAvobenzone, Ensulizole, Octinoxate, And Oxybenzone
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2010-08-15
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart352
Labeler NameVentura International LTD
Substance NameAVOBENZONE; ENSULIZOLE; OCTINOXATE; OXYBENZONE
Active Ingredient Strength1 g/50g; g/50g; g/50g; g/50g
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 14783-049-61

1 JAR in 1 BOX (14783-049-61) > 50 g in 1 JAR (14783-049-62)
Marketing Start Date2010-08-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 14783-049-62 [14783004962]

LBel Paris Regression Jour CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15

NDC 14783-049-61 [14783004961]

LBel Paris Regression Jour CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
AVOBENZONE1 g/50g

OpenFDA Data

SPL SET ID:024de8f0-1d3a-4761-8674-5d1a8ac9133c
Manufacturer
UNII

NDC Crossover Matching brand name "LBel Paris Regression Jour" or generic name "Avobenzone, Ensulizole, Octinoxate, And Oxybenzone"

NDCBrand NameGeneric Name
14783-035LBel Paris Regression JourLBel Paris Regression Jour
14783-055LBel Paris Regression JourLBel Paris Regression Jour
14783-045LBel Paris Regression JourLBel Paris Regression Jour
14783-039LBel ParisAvobenzone, Ensulizole, Octinoxate, and Oxybenzone
14783-049LBel ParisAvobenzone, Ensulizole, Octinoxate, and Oxybenzone
13537-025LBEL REGRESSION JOURAvobenzone, Ensulizole, Octinoxate, and Oxybenzone
14783-025LBEL REGRESSION JOURAvobenzone, Ensulizole, Octinoxate, and Oxybenzone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.